12.40

4.29% 0.51

After Hours: 12.89 0.49 +3.95%

Kura Oncology Inc (KURA)

Overview News Price History Option Chain Financials Discussions Forecast

Kura Oncology Inc stock is traded at $12.40, with a volume of 2.66M. It is up +4.29% in the last 24 hours and up +19.35% over the past month. Kura Oncology Inc is a biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for the treatment of cancer. The company develops small-molecule medicines designed to target cancer signaling pathways in oncology and hematology. Its pipeline includes menin inhibitor ziftomenib for the treatment of acute myeloid leukemia and other hematologic malignancies, as well as additional product candidates such as KO-7246 and darolifarnib being evaluated for solid tumors and other diseases.

Previous Close:

$11.89

Open:

$11.77

24h Volume:

2.66M

Relative Volume:

1.42

Market Cap:

$1.10B

Revenue:

$71.64M

Net Income/Loss:

$-294.57M

P/E Ratio:

-3.7037

EPS:

-3.348

Net Cash Flow:

$-84.46M

1W Performance:

+9.93%

1M Performance:

+19.35%

6M Performance:

+47.97%

1Y Performance:

+62.09%

1-Day Range:

$11.43

$12.87

1-Week Range:

$11.43

$12.90

52-Week Range:

$7.3575

$12.90

Kura Oncology Inc Stock (KURA) Company Profile

Name

Kura Oncology Inc

Sector

Healthcare (1033)

Industry

Biotechnology (582)

Phone

(858) 500-8800

Address

4930 DIRECTORS PLACE, SUITE 500, SAN DIEGO, CA

Employee

260

Twitter

@kuraoncology

Next Earnings Date

2026-08-12

Latest SEC Filings

KURA's Discussions on Twitter

Compare KURA vs VRTX, REGN, ARGX, MRNA, RVMD

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
KURA Kura Oncology Inc	12.40	1.04B	71.64M	-294.57M	-84.46M	-3.348
VRTX Vertex Pharmaceuticals Inc	547.59	136.93B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	828.50	85.11B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	1,011.11	64.95B	4.16B	1.29B	734.26M	19.58
MRNA Moderna Inc	138.89	53.23B	2.23B	-3.19B	-1.60B	-8.1462
RVMD Revolution Medicines Inc	211.58	45.38B	742.00K	-1.37B	-1.07B	-7.0731

Kura Oncology Inc Stock (KURA) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Apr-14-26	Initiated	Lake Street	Buy
Sep-04-25	Initiated	Guggenheim	Neutral
Feb-06-25	Downgrade	BTIG Research	Buy → Neutral
Oct-24-24	Initiated	UBS	Buy
Oct-14-24	Downgrade	Stifel	Buy → Hold
Dec-22-23	Initiated	Mizuho	Buy
Aug-11-23	Initiated	BofA Securities	Buy
Jul-27-23	Initiated	Scotiabank	Sector Perform
May-17-23	Initiated	BTIG Research	Buy
Jan-31-23	Initiated	Stifel	Buy
Jul-12-22	Initiated	Cantor Fitzgerald	Overweight
Feb-15-22	Initiated	Jefferies	Buy
May-05-21	Resumed	Credit Suisse	Outperform
Apr-26-21	Resumed	Credit Suisse	Outperform
Dec-07-20	Reiterated	H.C. Wainwright	Buy
Dec-03-20	Initiated	Stifel	Buy
Nov-05-20	Downgrade	Piper Sandler	Overweight → Neutral
Jul-07-20	Initiated	Credit Suisse	Outperform
May-05-20	Initiated	Barclays	Overweight
Jul-18-19	Initiated	Deutsche Bank	Buy
Nov-09-18	Initiated	Piper Jaffray	Overweight
Aug-01-18	Initiated	H.C. Wainwright	Buy
Oct-13-16	Resumed	Leerink Partners	Outperform
Jan-22-16	Initiated	JMP Securities	Mkt Outperform
Dec-30-15	Initiated	Oppenheimer	Outperform
Dec-16-15	Initiated	Citigroup	Buy

View All

Kura Oncology Inc Stock (KURA) Latest News

Aug 21, 2026

Kura Oncology (KURA) Chief Legal Officer Teresa Bair Sells 31,48 - GuruFocus

Aug 21, 2026

Kura Oncology (NASDAQ:KURA) Insider Sells 31,487 Shares - MarketBeat

Aug 21, 2026

Kura Oncology (NASDAQ: KURA) affiliate flags 4,345-share Rule 144 sale - Stock Titan

Aug 21, 2026

Kura Oncology (KURA) counsel offloads shares via 10b5-1 plan - Stock Titan

Aug 21, 2026

Great Lakes Advisors LLC Invests $2.85 Million in Kura Oncology, Inc. $KURA - MarketBeat

Aug 21, 2026

Aug 19, 2026

Kura Oncology (NASDAQ:KURA) Gains Traction With Its AML Menin Inhibitor - Kalkine Media

Aug 19, 2026

Troy Wilson Bought 12% More Shares In Kura Oncology - simplywall.st

Aug 19, 2026

Aug 18, 2026

Teleconferência de Resultados do 2º Trimestre de 2026 da Kura Oncology (KURA): Vendas do KOMZIFTI Atingem US$ 9,1 Milhões - TradingKey

Aug 18, 2026

Kura Oncology (NASDAQ:KURA) Hits New 52-Week High Following Insider Buying Activity - MarketBeat

Aug 18, 2026

Kura Oncology stock hits 52-week high at 12.49 USD - Investing.com

Aug 18, 2026

Does Kura Oncology (KURA) Have the Potential to Rally 178.55% as Wall Street Analysts Expect? - Yahoo Finance

Aug 18, 2026

Why Kura Oncology (KURA) Is Up 14.5% After New Ziftomenib Resistance Data And Q2 Results - Yahoo Finance

Aug 18, 2026

Aug 17, 2026

Kura Oncology stock rises on CEO insider purchase By Investing.com - Investing.com South Africa

Aug 17, 2026

Why Is KURA Stock Rallying 8% After-Hours? - TradingView

Aug 17, 2026

Kura Oncology stock rises on CEO insider purchase - Investing.com

Aug 17, 2026

Kura Oncology CEO Troy Wilson Acquires 100,000 Shares at $11.12 Each - Kalkine Media

Aug 17, 2026

Troy Edward Wilson Purchases 100,000 Shares of Kura Oncology (NASDAQ:KURA) Stock - MarketBeat

Aug 17, 2026

Kura Oncology (NASDAQ: KURA) CEO buys more in 100,000-share insider trade - Stock Titan

Aug 17, 2026